Our research further revealed that inhibiting SENP1 could result in the downregulation of target genes, including TK1, GMNN, CDK1, and CCNA2 [33–35], leading to cell cycle arrest at the G0/1 phase, which in turn suppresses ESCC development. The gene discussed is GMNN; the disease is esophageal squamous cell carcinoma.